Drug Approval | August 26, 2021
Wockhardt and Jemincare partner for novel respiratory antibiotic Nafithromycin
The company to receive upfront and milestone payments, in addition to royalties
The company to receive upfront and milestone payments, in addition to royalties
Clinical studies conducted in India demonstrated that this nebulized triple therapy rapidly improves lung function and offers better control of breathlessness
Itvisma is a one-time, fixed-dose therapy designed to tackle the genetic root cause of SMA
The multibillion-dollar Maryland expansion is part of AstraZeneca’s sweeping $50 billion global investment plan
ALBIS will present a selection of advanced materials from its broad healthcare portfolio
The approval granted with zero supplementation requests is an important milestone in Glenmark’s respiratory pipeline
The pharma giant's 11% rise in total revenue to $43.2 billion highlights consistent execution of its growth strategy
Comirnaty, Pfizer’s COVID-19 prevention vaccine, reported global sales of $1.15 billion
The upcoming state-of-the art 400+ bed facility is set to come up at an approximate cost of Rs 500 crore
Vitiligo, affecting over 90 per cent of patients in its non-segmental form, is characterized by symmetrical white patches on both sides of the body
Subscribe To Our Newsletter & Stay Updated
